(Q36488800)

14 August 2017

Periodontal disease in a patient receiving Bevacizumab: a case report (English)

1 reference

14 August 2017

1 reference

1 reference

Dorothy M Gujral

1

1 reference

14 August 2017

Sanjeev Bhattacharyya

series ordinal

2

1 reference

14 August 2017

Peter Hargreaves

series ordinal

3

1 reference

14 August 2017

Gary W Middleton

series ordinal

4

1 reference

14 August 2017

language of work or name

English

0 references

publication date

13 February 2008

1 reference

Journal of Medical Case Reports

14 August 2017

1 reference

14 August 2017

2

1 reference

14 August 2017

47

1 reference

Creative Commons Attribution 2.0 Generic

14 August 2017

start time

13 February 2008

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

cites work

Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2262909

Bevacizumab in the treatment of metastatic colorectal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2262909

Gastrointestinal perforation due to bevacizumab in colorectal cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2262909

Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2262909

Medications: a risk factor for periodontal disease diagnosis and treatment

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2262909

Intravitreal bevacizumab therapy for choroidal neovascularization secondary to age-related macular degeneration: 6-month results of an open-label uncontrolled clinical study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2262909

Vascular endothelial growth factor in gingival tissues and crevicular fluids of diabetic and healthy periodontal patients

28 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1752-1947-2-47

Periodontitis and systemic diseases

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2262909

Bowel perforation from bevacizumab for the treatment of metastatic colon cancer: incidence, etiology, and management

21 September 2018

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF) levels of gingiva and gingival crevicular fluid in diabetic and systemically healthy periodontitis patients

1 reference

12 December 2020

Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema

1 reference

12 December 2020

Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation

1 reference

12 December 2020

Identifiers

DOI

10.1186/1752-1947-2-47

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

18271967

1 reference